Fasting serum C-peptide is useful for initial classification of diabetes mellitus in children and adolescents
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Purpose: With rising obesity rates in children, it is increasingly difficult to differentiate between type 1 and type 2 diabetes mellitus (T1DM, T2DM) on clinical grounds alone. Using C-peptide as a method of classifying diabetes mellitus (DM) has been suggested. This study aimed to find a correlation between fasting C-peptide level and DM types in children and adolescents. Methods: A total of 223 diabetic children, newly diagnosed at 5 hospitals between January 2001 and December 2012, were enrolled in this study. Initial DM classification was based on clinical and laboratory data including fasting C-peptide at diagnosis; final classification was based on additional data (pancreatic autoantibodies, human leukocyte antigen type, and clinical course). Results: Of 223 diabetic children, 140 were diagnosed with T1DM (62.8%) and the remaining 83 with T2DM (37.2%). The mean serum C-peptide level was significantly lower in children with T1DM (0.80 ng/mL) than in children with T2DM (3.91 ng/ mL). Among 223 children, 54 had a serum C-peptide level <0.6 ng/mL; they were all diagnosed with T1DM. The proportion of children with T2DM increased in accordance with C-peptide level. Forty-nine of 223 children had a C-peptide level >3.0 ng/mL; 48 of them (97.9%) were diagnosed with T2DM. Conclusion: In this study, we found that if the C-peptide level was <0.6 ng/mL at diagnosis, T2DM could be excluded; if C-peptide level was >3.0 ng/mL, a T1DM diagnosis is unlikely. This finding suggests that serum fasting C-peptide level is useful for classifying DM type at the time of diagnosis in youth.
Abstract
Purpose: With rising obesity rates in children, it is increasingly difficult to differentiate between type 1 and type 2 diabetes mellitus (T1DM, T2DM) on clinical grounds alone. Using C-peptide as a method of classifying diabetes mellitus (DM) has been suggested. This study aimed to find a correlation between fasting C-peptide level and DM types in children and adolescents. Methods: A total of 223 diabetic children, newly diagnosed at 5 hospitals between January 2001 and December 2012, were enrolled in this study. Initial DM classification was based on clinical and laboratory data including fasting C-peptide at diagnosis; final classification was based on additional data (pancreatic autoantibodies, human leukocyte antigen type, and clinical course). Results: Of 223 diabetic children, 140 were diagnosed with T1DM (62.8%) and the remaining 83 with T2DM (37.2%). The mean serum C-peptide level was significantly lower in children with T1DM (0.80 ng/mL) than in children with T2DM (3.91 ng/ mL). Among 223 children, 54 had a serum C-peptide level <0.6 ng/mL; they were all diagnosed with T1DM. The proportion of children with T2DM increased in accordance with C-peptide level. Forty-nine of 223 children had a C-peptide level >3.0 ng/mL; 48 of them (97.9%) were diagnosed with T2DM. Conclusion: In this study, we found that if the C-peptide level was <0.6 ng/mL at diagnosis, T2DM could be excluded; if C-peptide level was >3.0 ng/mL, a T1DM diagnosis is unlikely. This finding suggests that serum fasting C-peptide level is useful for classifying DM type at the time of diagnosis in youth.
참고문헌 (24)
- Daneman D, "Type 1 diabetes", Lancet, 367, pp.847~858 (2006)
- Gungor N, "Type 2 diabetes mellitus in youth: the complete picture to date", Pediatr Clin North Am, 52, pp.1579~1609 (2005)
- Harron KL, "Rising rates of all types of diabetes in south Asian and non-south Asian children and young people aged 0-29 years in West Yorkshire, U.K., 1991-2006", Diabetes Care, 34, pp.652~654 (2011)
- American Diabetes Association, "Type 2 diabetes in children and adolescents", Pediatrics, 105(3 Pt 1), pp.671~680 (2000)
- Katz LE, "Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis", Pediatr Diabetes, 8, pp.53~59 (2007)
- Ludvigsson J, "C-peptide in the classification of diabetes in children and adolescents", Pediatr Diabetes, 13, pp.45~50 (2012)
- Hattersley A, "ISPAD Clinical Practice Consensus Guidelines 2006-2007. The diagnosis and management of monogenic diabetes in children", Pediatr Diabetes, 7, pp.352~360 (2006)
- Pearson ER, "Genetic cause of hyperglycaemia and response to treatment in diabetes", Lancet, 362, pp.1275~1281 (2003)
- Byrne MM, "Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20", Diabetes, 44, pp.699~704 (1995)
- Besser RE, "Determination of C-peptide in children: when is it useful?", Pediatr Endocrinol Rev, 10, pp.494~502 (2013)
- "Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus", Diabetes Care, 20, pp.1183~1197 (1997)
- D'Adamo E, "Type 2 diabetes in youth:epidemiology and pathophysiology", Diabetes Care, 34(Suppl 2), pp.S161~S165 (2011)
- Garcia-Webb P, "Correlation between fasting serum C-peptide and B cell insulin secretory capacity in diabetes mellitus", Diabetologia, 22, pp.296~ (1982)
- Webb PG, "Basal C-peptide in the discrimination of type I from type II diabetes", Diabetes Care, 4, pp.616~619 (1981)
- Service FJ, "The classification of diabetes by clinical and C-peptide criteria. A prospective population-based study", Diabetes Care, 20, pp.198~201 (1997)
- Hother-Nielsen O, "Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables", Diabetes Care, 11, pp.531~537 (1988)
- Gjessing HJ, "Correlations between fasting plasma C-peptide, glucagon-stimulated plasma C-peptide, and urinary C-peptide in insulin-treated diabetics", Diabetes Care, 10, pp.487~490 (1987)
- The Korean Society of Pediatric Endocrinology, "Pediatric endocrinology" (1996), Kwangmoon Press
- 박지윤, "소아의 1형 및 2형 당뇨병 감별에 있어서 임상적 특징 및 자가 항체 검사의 유용성", Annals of Pediatirc Endocrinology & Metabolism, 16(2), pp.119~127 (2011), 대한소아내분비학회
- Hur J, "Clinical characteristics of type 1diabetes mellitus at initial Diagnosis", J Korean Soc Pediatr Endocrinol, 11, pp.177~184 (2006)
- Lee CW, "Prevalence of autoimmune antibodies in type i diabetic children and their siblings", J Korean Soc Pediatr Endocrinol, 4, pp.78~87 (1999)
- 홍은희, "2001-2008년 진단된 소아당뇨병의 분포와 특징", Annals of Pediatirc Endocrinology & Metabolism, 14(2), pp.110~115 (2009), 대한소아내분비학회
- Yu J, "Analysis of children with type 1 diabetes in Korea: high prevalence of specific anti-islet autoantibodies, immunogenetic similarities to Western populations with "unique"haplotypes, and lack of discrimination by aspartic acid at position 57 of DQB", Clin Immunol, 113, pp.318~325 (2004)
- Ludvigsson J, "C-peptide in children with juvenile diabetes: a preliminary report", Diabetologia, 12, pp.627~630 (1976)